Abstract

Introduction: Patients with primary hyperparathyroidism (PHPT) can be asymptomatic or have a normal calcium level (NHPT). Patients with 25(OH) vitamin D insufficiency, on the other hand, may present with a similar presentation. In regions where 25(OH) vitamin D deficiency is common, patients are usually diagnosed with secondary hyperparathyroidism (SHPT). Therefore, it is necessary to separate PHPT and NHPT from SHPT. Parathormone and calcium values are used for differentiation in the clinic. The predictive value of the newly developed parathyroid function test (PFindex), which previously had a high diagnostic value, was evaluated in this patient population in our investigation.Methods: The study comprised 163 PHPT and NHPT patients with pathological confirmation and 56 SHPT patients. The PHPT, NHPT, and SHPT properties were defined using PFindex. The diagnostic power of PFindex was investigated using a receiver operating characteristic (ROC) curve of the results assessed in three groups.Results: The PHPT group had the highest PFindex (1365.4±784.6) compared to the other two groups (NHPT: 723.5±509.4; SHPT:227.2±49.9, all p < 0.001). A PFindex threshold of 327.8 yielded 91.9% and 90.9% sensitivity and specificity rates for distinguishing PHPT and NHPT from SHPT, respectively.Conclusion: PFindex gave the outstanding diagnostic capacity to distinguish PHPT from SHPT due to our research. This straightforward tool can assist in making quick decisions about vitamin D therapy or surgery for PHPT.

Highlights

  • Patients with primary hyperparathyroidism (PHPT) can be asymptomatic or have a normal calcium level (NHPT)

  • The diagnostic power of parathyroid function index (PFindex) was investigated using a receiver operating characteristic (ROC) curve of the results assessed in three groups

  • Our study aims to re-examine the power of this diagnostic tool, which has been published only once in the literature and has a high predictive value in a population where vitamin D deficiency is common

Read more

Summary

Introduction

Patients with primary hyperparathyroidism (PHPT) can be asymptomatic or have a normal calcium level (NHPT). Parathyroid hormone (PTH) is an 84-amino-acid polypeptide hormone produced by the pituitary gland. It is released by the parathyroid glands and is one of the most essential hormones for maintaining blood calcium (Ca) and phosphate (PO4) balance. It causes 25(OH)D to be hydroxylated to 1,25(OH)2D, resulting in intestinal calcium absorption and supporting calcium and phosphate release from the bone. Primary hyperparathyroidism (PHPT) is a condition that affects calcium metabolism due to parathyroid hormone (PTH) hypersecretion in one or more of the four parathyroid glands. PHPT is considered the most common cause of hypercalcemia in ambulatory patients [5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call